An Observational, Comparative, Multi Centre Study, Validating the Structured Light Plethysmography Against Standard of Care (Spirometry) in the Diagnosis of Chronic Obstructive Pulmonary Disease for Patients Who Plan to Undergo Spirometry Testing
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COPD
- Healthy Smoker
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
This is an observational, comparative, multicentre study to validate the Thora3Di™ against standard practice in patients who are undergoing investigation for COPD. The core methodology involves capturing of data during a short period of measurement of breathing using SLP against spirometric outcomes...
This is an observational, comparative, multicentre study to validate the Thora3Di™ against standard practice in patients who are undergoing investigation for COPD. The core methodology involves capturing of data during a short period of measurement of breathing using SLP against spirometric outcomes. This study is a comparative study with two study visits (Part A and Part B ) to generate data to characterise the tidal breathing patterns and parameters with Thora3Di™againt spirometry FEV1/FVC and %predicted. Subjects will have a Part A visit 1(Development Phase), and a Part B visit 2(Validation Phase) after developing algorithms for COPD diagnosis from Part A. At Part A visit 1, subjects will have two 5-minute SLP measurements (Pre and Post bronchodilator). At Part B visit 2, subjects will be seen in the clinics and have three 5-minute SLP measurements (pre-bronchodilator, post-bronchodilator and post spirometry testing) along with spirometry testing (pre-bronchodilator and post-bronchodilator). The SLP measurement should be performed prior to standard lung function tests with minimal impact on clinical time and no change to hospital attendance. Also, each visit subjects will be asked to report concomitant medications and adverse events, and fill in COPD assessment test (CAT™).
Tracking Information
- NCT #
- NCT04584801
- Collaborators
- Not Provided
- Investigators
- Study Chair: Mona Bafadhel, PhD Oxford University Hospitals NHS Trust Principal Investigator: Dennis Wat, MD Liverpool Heart and Chest Hospital NHS Trust Principal Investigator: Brendan Cooper, PhD University of Birmingham Hospital NHS Foundation Trust Principal Investigator: Paul Walker, MD Liverpool University Hospital NHS Foundation Trust Principal Investigator: Richa Singh, MD London Barts Health NHS Foundation Trust Principal Investigator: Mitra Shahidi, MD Buckinghamshire Healthcare NHS Trust